7 results
Acute-on-Chronic Liver Failure (ACLF) Clinical Guidelines

ACLF = possibly reversible condition in those with CLD (± cirrhosis)
in those with CLD ... months without treatment ... Brain Failure Lung ... Hepatitis (AAH) Drug-Induced ... #diagnosis
Algorithm for Management of Acute Exacerbation of COPD (AECOPD)

Obtain workup for alternate diagnoses and relevant comorbidities:
Algorithm for Management ... for alternate diagnoses ... limitation (GOLD Ill ... ventilated • CXR, Lung ... #treatment #pulmonary
Amiodarone Induced Lung Toxicity Summary

Who?
• 5% of patients
• Dose ≥ 400 mg per day

How?  Possible
• Amiodarone half ... Dyspnea 3. ... Exclusion of other ILDs ... #Pulmonary #diagnosis ... #management #Toxicology
Cryptogenic Organizing Pneumonia (COP)

Cryptogenic Organizing Pneumonia Overview:
 • Idiopathic form of organizing pneumonia
 • formerly BOOP
History: cough, dyspnea ... Organizing Pneumonia - Diagnosis ... Organizing Pneumonia Treatment ... #ILD #diagnosis ... #management
Pheochromocytoma - Diagnosis and Management Summary
10 percent rule = 10% of pheochromocytomas are extra-adrenal, multiple, bilateral,
• Headache → mild ... tremor, pallor, dyspnea ... similar to stress-induced ... may present with pulmonary ... #Management #treatment
Macrophage Activation Syndrome (MAS)
Classified among the secondary or acquired forms of haemophagocytic lymphohistiocytosis (sHLH)

What?
A subset of
rash) • Heart, lung ... Sepsis • Drug-induced ... Treatment: • Corticosteroids ... Activation #Syndrome #Diagnosis ... #Management #Hematology
Anti-NXP-2 Dermatomyositis

What?
DM with generalized subcutaneous edema
Pts have more myalgias, more severe weakness, and an increased prevalence
Periorbital heliotrope (blue-purple ... Dermatomyositis: • ILD ... positive patients Treatment ... #management #rheumatology ... #dermatology